SITC Archive Library

SITC 31st Annual Meeting (2016): Concurrent Session III: Emerging Technologies 

05-03-2018 15:53

The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session III: Emerging Technologies" during the SITC 31st Annual Meeting & Associated Programs on November 11-13, 2016. Available here are the presentation slides and video from the session.

Co-Chairs:

  • Edward C. Stack, PhD – PerkinElmer
  • David A. Zaharoff, PhD – University of North Carolina, Chapel Hill & North Carolina State University

Program Summary

The development of emerging technologies promises to enable the continuing rise of cancer immunotherapies. The scope of new technologies is exceptionally broad and ranges from ‘armored’ CAR T cells to bispecific T cell engagers to next generation sequencing to humanized animal models and beyond. This session will focus in particular on multiplexed immunohistochemistry (mIHC) and cancer immunotherapy delivery systems. Regarding the former, the therapeutic benefits now engendered by immune checkpoint inhibitors, such as PD-1, PD-L1 and CTLA-4, fundamentally challenge the strategies used to interrogate such advantages. We must now contend with understanding the contextual interplay between immune cells and tumors cells within a complex tumor microenvironment, in order to more firmly stratify responsiveness. Thus, this session tackled the complexities associated with mIHC and how this emerging technology is opening up contextual interactions between specific myeloid components and classic Hodgkin’s lymphoma. Regarding delivery systems, engineers and physicians are working side-by-side to construct efficient delivery platforms capable of enhancing antitumor immunity. Unlike traditional delivery of cytotoxic drugs, the delivery of antigens and immunotherapeutics requires intelligent design and a more nuanced approach. These challenges are being met by bringing to bear multidisciplinary efforts in this rapidly evolving field. It’s hoped that by highlighting novel mIHC capacities and novel delivery methods, that this session on emerging technologies will improve the ability to incorporate such capacity in the study of cancer and immunotherapy as it marches toward a cure.

Intended Audience

The audience includes U.S. and international researchers, regulators and healthcare professionals involved in cancer research and clinical care. This includes, but is not limited to basic, translational and clinical researchers; postdoctoral fellows; oncologists; registered nurses; nurse practitioners; pharmacists; payers; and other allied health professionals.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#BladderCancer#PresentationSlides#Video#AnnualMeeting#SITC
#Cytokines#AlliedHealth#Clinician#RegisteredNurse#Oncologist
#Pharmacist#Researcher#2016

Statistics
0 Favorited
23 Views
4 Files
0 Shares
26 Downloads
Attachment(s)
pdf file
IL-12 Immunotherapy for the Treatment of Bladder Cancer" ...   4.50 MB   1 version
Uploaded - 05-03-2018
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session III: Emerging Technologies; Presenter: Sean G. Smith – University of North Carolina, Chapel Hill and North Carolina State University; Date: November 12, 2016
mp4 file
IL-12 Immunotherapy for the Treatment of Bladder Cancer" ...   135.84 MB   1 version
Uploaded - 05-03-2018
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session III: Emerging Technologies; Presenter: Sean G. Smith – University of North Carolina, Chapel Hill and North Carolina State University; Date: November 12, 2016
pdf file
A Novel Bioinformatics Tool for Analysis of T Cell Recep...   4.16 MB   1 version
Uploaded - 05-03-2018
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session III: Emerging Technologies; Presenter: John-William Sidhom – Johns Hopkins University; Date: November 12, 2016
mp4 file
A Novel Bioinformatics Tool for Analysis of T Cell Recep...   157.24 MB   1 version
Uploaded - 05-03-2018
Meeting: SITC 31st Annual Meeting; Session: Concurrent Session III: Emerging Technologies; Presenter: John-William Sidhom – Johns Hopkins University; Date: November 12, 2016